Mainstay Medical announces commercial launch of ReActiv8 in Australia
Mainstay Medical Holdings recently announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back...
Read MoreMedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors
Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from...
Read MoreSacrix develops new iteration of SacroFuse for sacroiliac joint support
US-based medical device company Sacrix has developed the third iteration of the SacroFuse threaded compression device for immediate stabilisation of...
Read MoreRABEA by SIGNUS – gold standard in anterior cervical fusion
Promotional feature RABEA® SIGNUS developed the first plan-parallel fusion cage worldwide. RABEA® received CE approval in 1996 and is,...
Read MoreBIG ST – ONE design, many options
Promotional feature BIG ST – ONE Design – many options With the BIG ® ST ALIF Cage, SIGNUS expands...
Read MoreST-Line – Next in fusion
Promotional feature With its new ST-Line, SIGNUS has applied the progress from endoprosthetic research to spinal surgery Regardless of the...
Read MoreSuccess of first JASPIS ST® surgery in Australia
Neurosurgeon Dr Andrew Miles, Neurospine Institute, Western Australia successfully completed the first JASPIS® ST surgery in Australia. Dr Miles’ first...
Read MoreMore appealing, more informative and with new functions: the revised SIGNUS website is online
Since the end of August SIGNUS presents itself with a new website. The new online presence offers clearly arranged and...
Read More